Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02246413 · ClinicalTrials.gov registry record · NA

Research Aimed at Improving Both Mood and Weight

A NA study, sponsored by Palo Alto Medical Foundation.

Completed
Registry status
NA
Development phase
409
Enrollment target

NCT02246413 is a NA study that has completed, run by Palo Alto Medical Foundation. The registered enrollment target is 409 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02246413, a NA study, has completed, sponsored by Palo Alto Medical Foundation.

COMPLETED
Registry status
NA
Development phase
409 participants
Enrollment target

Study Summary

The RAINBOW study is an NIH R01-funded randomized controlled trial to evaluate the clinical and cost effectiveness and implementation potential of a primary care integrated multicondition intervention program to help improve mood and weight for obese adults with clinically significant depressive symptoms. The ENGAGE study is a mechanistic investigation added to the main trial with funding through the NIH common fund for the Science of Behavior Change roadmap initiative. Beginning Jan 11, 2016, at least 100 of newly enrolled trial participants will be consented to undergo additional assays evaluating neurobiological mechanisms of self-regulation.

Interventions

  • BEHAVIORAL RAINBOW Intervention Program

Trial Details

FieldValue
Enrollment Target 409 participants
Start Date 2014-09-30
Est. Completion 2018-12-21
Phase NA

Sponsor

Palo Alto Medical Foundation

11 total trials

What the Registry Record Tells You About NCT02246413

The ClinicalTrials.gov registry entry for NCT02246413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 409 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Medical Foundation, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which RAINBOW Intervention Program is the first listed.

NCT02246413 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02246413 about?

NCT02246413 is a clinical study titled "Research Aimed at Improving Both Mood and Weight". The RAINBOW study is an NIH R01-funded randomized controlled trial to evaluate the clinical and cost effectiveness and implementation potential of a primary care integrated multicondition intervention program to help improve mood and weight for obese adults with clinically significant depressive sym...

What is the current status of trial NCT02246413?

This trial is currently completed. It is a NA study. The enrollment target is 409 participants. The study started on 2014-09-30. Estimated completion is 2018-12-21.

What interventions are being tested in trial NCT02246413?

The interventions under investigation include: RAINBOW Intervention Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02246413?

This trial is sponsored by Palo Alto Medical Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.